With no portraits of Rhode Island theologian Roger Williams to go by, sculptor based image on the Splendid Splinter ...
Keegan Reilly is running not only in memory of his boss’ wife, but also for his grandmother, who is currently batting ...
Three Florida men, united under a common goal of helping advance cancer research, will be running the iconic 129th Boston ...
Health and Me on MSN8h
FDA Approves Cabozantinib For Neuroendocrine TumorsThe approval came on the bases of the results from the phase 3 CABINET study. The study compared cabozantinib to a placebo in ...
SIGN UP TO CONTINUEPrint Subscriber? Sign Up for Full Access!Please sign up for as low as 36 cents per day to continue ...
Three Florida men, united under a common goal of helping advance cancer research, will be running the iconic 129th Boston ...
Oncologists share how to prioritize yourself while undergoing the difficult treatment, and real women share how positive ...
A Democratic member of Congress has emerged as a vocal defender of the status quo at the National Institutes of ...
More than half of patients recently diagnosed with lymphoma or myeloma had clinically significant symptoms of anxiety or ...
The U.S. Food and Drug Administration has approved cabozantinib (Cabometyx), an oral tyrosine kinase inhibitor, for patients ...
Jennifer Chan, MD, MPH, discussed the findings from the phase 3 CABINET trial leading to the FDA approval of cabozantinib in patients with neuroendocrine tumors.
Colorectal cancer was found to be the most common malignancy and cause of death among patients with classic familial adenomatous polyposis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback